EMA establishes a Cancer Medicines Forum to optimize Cancer Treatments in Clinical practice
Summary EMA has launched the Cancer Medicines Forum (CMF) in collaboration with the European Organization for Research and Treatment of Cancer (EORTC).…
Summary EMA has launched the Cancer Medicines Forum (CMF) in collaboration with the European Organization for Research and Treatment of Cancer (EORTC).…
Summary : AstraZeneca has failed in its bid to get US approval for its IL-5 inhibitor Fasenra as a treatment for chronic…
Summary : The largest study to date has confirmed the link between the gut microbiome and the response to cancer immunotherapy therapy…
Synopsis: GlaxoSmithKline has voluntarily paused activities in its Phase III GRACE trial on an experimental maternal vaccine for respiratory syncytial virus (RSV).…
In 2021, EMA recommended 92 medicines for marketing authorisation. Of these, 53 had a new active substance which had never been authorised…
Summary : EMA’s human medicines committe has recommended granting conditional marketing authorisation for the oral antiviral medicine Paxlovid (PF-07321332 / ritonavir) for…
Synopsis : In November 2018, Cipla had announced that InvaGen Pharmaceuticals Inc has entered into definitive agreements to acquire US-based speciality business…
Summary ; -Oncoheroes will fund and advance the clinical development of both dovitinib and stenoparib in pediatric cancers, utilizing Allarity’s DRP® companion…
Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company, today announced that Todos Medical President & CEO Gerald…
Summary : Received the CES 2022 Innovation Awards in Health and Wellness following a CES 2018 Best of Innovation Award in VR/AR…